BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25230150)

  • 1. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
    Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ
    Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
    Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
    Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
    Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.
    Douglas CM; Bernstein JM; Ormston VE; Hall RC; Merve A; Swindell R; Valentine HR; Slevin NJ; West CM; Homer JJ
    Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):59-65. PubMed ID: 22841149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
    Franklin S; Pho T; Abreo FW; Nassar R; De Benedetti A; Stucker FJ; Nathan CO
    Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
    Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
    van den Bovenkamp K; van der Vegt B; Halmos GB; Slagter-Menkema L; Langendijk JA; van Dijk BAC; Schuuring E; van der Laan BFAM
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3801-3809. PubMed ID: 37029804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
    Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
    Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.
    Lukits J; Timár J; Juhász A; Döme B; Paku S; Répássy G
    Otolaryngol Head Neck Surg; 2001 Jul; 125(1):18-22. PubMed ID: 11458208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
    Yang CJ; Kim DY; Lee JH; Roh JL; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2013 Dec; 108(8):509-15. PubMed ID: 24590673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum carbonic anhydrase IX predicts shorter survival in head and neck cancer.
    Rosenberg V; Pastorekova S; Zatovicova M; Vidlickova I; Jelenska L; Slezak P
    Bratisl Lek Listy; 2016; 117(4):201-4. PubMed ID: 27075382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.